Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo
- PMID: 8759769
Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo
Abstract
This study was undertaken to directly assess the susceptibility of HIV-1 plasma virus to C-mediated lysis. Plasma from HIV-infected individuals was collected and ultracentrifuged over 20% sucrose to isolate virions from plasma components including anticoagulants, which inhibit C activity. Treatment with C alone in the absence of exogenously added Ab caused lysis of virus from all patients (n = 18) (range 14 to 86%). This lysis occurred via the classical C pathway and was not due to cross-reactive Abs in the C source. Protein A bound a fraction of isolated plasma virus and this binding was blocked by purified human Ig suggesting that anti-HIV Abs bound to plasma virus could be responsible for inducing C activation. A portion of virus bound to CR2 on cells in the absence of exogenously added C indicating that virus activated C in vivo. C levels from six of six patients were determined to be sufficient to lead to lysis of virus in vivo. Since plasma virus appeared more sensitive to C than primary isolates, isolated virus was evaluated for the presence of C control proteins. While primary isolate virions contained CD46, CD55, and CD59, only CD59 was detected on plasma virus. The results of this study strongly suggest that C is activated by a portion of plasma virus in vivo due to the binding of Ab. The resultant opsonization plus subsequent lysis may be important routes of clearance and destruction of plasma virus in infected persons.
Similar articles
-
Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection.Virology. 1994 Nov 15;205(1):82-92. doi: 10.1006/viro.1994.1622. Virology. 1994. PMID: 7526538
-
Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.Lab Invest. 1996 Jan;74(1):33-42. Lab Invest. 1996. PMID: 8569195
-
Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV).J Immunol. 1995 Nov 1;155(9):4376-81. J Immunol. 1995. PMID: 7594597
-
Complement-opsonized HIV: the free rider on its way to infection.Mol Immunol. 2005 Feb;42(2):153-60. doi: 10.1016/j.molimm.2004.06.024. Mol Immunol. 2005. PMID: 15488605 Review.
-
Role of complement in HIV infection.Annu Rev Immunol. 1997;15:649-74. doi: 10.1146/annurev.immunol.15.1.649. Annu Rev Immunol. 1997. PMID: 9143703 Review.
Cited by
-
Nanobody-mediated complement activation to kill HIV-infected cells.EMBO Mol Med. 2023 Apr 11;15(4):e16422. doi: 10.15252/emmm.202216422. Epub 2023 Feb 17. EMBO Mol Med. 2023. PMID: 36799046 Free PMC article.
-
Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type 1 infection.J Virol. 2005 Mar;79(5):2823-30. doi: 10.1128/JVI.79.5.2823-2830.2005. J Virol. 2005. PMID: 15709001 Free PMC article.
-
Immune complexes containing human immunodeficiency virus type 1 primary isolates bind to lymphoid tissue B lymphocytes and are infectious for T lymphocytes.J Virol. 2000 Jan;74(1):552-5. doi: 10.1128/jvi.74.1.552-555.2000. J Virol. 2000. PMID: 10590148 Free PMC article.
-
Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1.J Virol. 2001 Jul;75(14):6558-65. doi: 10.1128/JVI.75.14.6558-6565.2001. J Virol. 2001. PMID: 11413323 Free PMC article.
-
Co- but not Sequential Infection of DCs Boosts Their HIV-Specific CTL-Stimulatory Capacity.Front Immunol. 2019 May 24;10:1123. doi: 10.3389/fimmu.2019.01123. eCollection 2019. Front Immunol. 2019. PMID: 31178863 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous